The influence of blood count, cardiovascular risks, inherited thrombophilia and JAK2 V617F burden allele on the type of thrombosis in patients with Ph(-) myeloproliferative neoplasms

ConclusionBased on our results, a new scoring system for thrombosis risk in PV could be made while PMF prognostic model may be expanded for better recognition of potential thrombotic risk factors.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research